|
TAF12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.764200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.551600E-01 |
| Normal-vs-Stage2 |
5.368400E-01 |
| Normal-vs-Stage3 |
1.289850E-01 |
| Normal-vs-Stage4 |
1.444470E-02 |
| Stage1-vs-Stage2 |
4.800600E-01 |
| Stage1-vs-Stage3 |
7.272500E-02 |
| Stage1-vs-Stage4 |
1.372190E-02 |
| Stage2-vs-Stage3 |
6.796000E-01 |
| Stage2-vs-Stage4 |
4.198200E-02 |
| Stage3-vs-Stage4 |
2.474200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.318200E-01 |
| Normal-vs-AfricanAmerican |
7.124400E-01 |
| Normal-vs-Asian |
1.328370E-01 |
| Caucasian-vs-AfricanAmerican |
2.874200E-01 |
| Caucasian-vs-Asian |
1.468170E-02 |
| AfricanAmerican-vs-Asian |
5.981300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.576600E-01 |
| Normal-vs-Female |
1.678410E-01 |
| Male-vs-Female |
1.952610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.705800E-01 |
| Normal-vs-Extreme_Weight |
5.586800E-01 |
| Normal-vs-Obese |
9.587400E-01 |
| Normal-vs-Extreme_Obese |
7.302000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.922400E-01 |
| Normal_Weight-vs-Obese |
7.253000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.977200E-01 |
| Extreme_Weight-vs-Obese |
6.466400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.602400E-01 |
| Obese-vs-Extreme_Obese |
7.298000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.726200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.496400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.267000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.802200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.517700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.346100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.322300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.803780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.661400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.595800E-01 |
| Normal-VS-Type2 PRCC |
5.754200E-01 |
| Normal-VS-KIRP CIMP |
1.656540E-03 |
| Normal-VS-Unclassified PRCC |
5.450800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.005600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.52749999818391E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
7.659200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.74259999985438E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
3.249000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.54538999999065E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.874600E-01 |
| Normal-vs-N1 |
4.922000E-02 |
| Normal-vs-N2 |
3.670600E-01 |
| N0-vs-N1 |
3.048000E-01 |
| N0-vs-N2 |
3.952800E-01 |
| N1-vs-N2 |
7.065800E-01 |
|
|
